Page 380 - IJB-9-6

International Journal of Bioprinting Aflatoxin B1-induced cancer stem cells

56. Yu Z, Pestell TG, Lisanti MP, et al., 2012, Cancer stem cells. 60. Zhou L, Sun Y, Ye G, et al., 2022, Effects of CD133 expression
Int J Biochem Cell Biol, 44(12): 2144–2151. on chemotherapy and drug sensitivity of adenoid cystic
carcinoma. Mol Med Rep, 25(1): 18.
57. Nguyen ST, Nguyen LS, Nguyen THP, et al., 2020, Isolation
of cancer stem-like cells from hepatocellular carcinoma cell 61. Hiroyuki T, Tomohiro K, Ayumi N, et al., 2017, Updates in
line HepG2 by methods of magnetic-activated cell sorting, Liver Cancer, Mohamed AH (ed.), IntechOpen, Rijeka.
spheroid culture, and anti-tumor drug-resistant selection: A 62. Wei Y, Li Y, Chen Y, et al., 2022, ALDH1: A potential
primary evaluation. Prog Stem Cell, 7(1-2): 279–289.
therapeutic target for cancer stem cells in solid tumors.
58. Dzobo K, Ganz C, Thomford NE, et al., 2021, Cancer stem Front Oncol, 12: 1026278.
cell markers in relation to patient survival outcomes: Lessons 63. Link T, Iwakuma T, 2017, Roles of p53 in extrinsic factor-
for integrative diagnostics and next-generation anticancer induced liver carcinogenesis Hepatoma Res, 3(6): 95–104.
drug development. Omics J Integr Biol, 25(2): 81–92.
64. Kawasaki Y, Adachi N, Yamazaki T, et al., 2007, Cancer stem
59. Lu R, Zhao G, Yang Y, et al., 2019, Inhibition of CD133 cells in aflatoxin B1-induced rat hepatocellular carcinoma
overcomes cisplatin resistance through inhibiting PI3K/ K2 cells. JSM Mycotoxins, 57: 87–93.
AKT/mTOR signaling pathway and autophagy in CD133-
positive gastric cancer cells. Technol Cancer Res Treatment, 65. Feng W-H, Xue KS, Tang L, et al., 2017, Aflatoxin B1-
18: 1533033819864311. induced developmental and DNA damage in caenorhabditis
elegans. Toxins, 9(1): 9.

Volume 9 Issue 6 (2023) 372 https://doi.org/10.36922/ijb.0985